Rafael Rosengarten is CEO and co-founder of Genialis, the company revolutionizing diagnostics and drug development with RNA and machine learning. He envisions a world in which healthcare delivers the best possible outcomes for patients, their families and communities. Before leading Genialis’ effort to realize the promise of precision medicine, he spent nearly 20 years in biomedical research, publishing in the fields of evolution, immunology, bioengineering and genetics. Dr. Rosengarten is also a board member and co-founder of the Alliance for AI in Healthcare (AAIH), a non-profit global advocacy organization. Rafael attended Dartmouth College before earning his doctorate from Yale University, where he was an NSF Graduate Research Fellow. He went on to postdoctoral training in Jay Keasling’s synthetic biology group at Lawrence Berkeley National Laboratory, Joint BioEnergy Institute (JBEI), where he co-invented the j5 DNA assembly design automation tool (which has since been commercialized by TeselaGen Biotechnology). This was followed by a National Library of Medicine fellowship in Biomedical Informatics at Baylor College of Medicine. In his free time, Rafael enjoys cooking, climbing mountains and exploring the world with his wife and two precocious children.